275 related articles for article (PubMed ID: 10353759)
1. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
2. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
Bouras T; Frauman AG
J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
[TBL] [Abstract][Full Text] [Related]
3. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
Sigala S; Bodei S; Missale C; Zani D; Simeone C; Cunico SC; Spano PF
Mol Cell Endocrinol; 2008 Mar; 284(1-2):11-20. PubMed ID: 18280641
[TBL] [Abstract][Full Text] [Related]
5. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
Yang X; Wei LL; Tang C; Slack R; Mueller S; Lippman ME
Cancer Res; 2001 Jul; 61(13):5284-8. PubMed ID: 11431371
[TBL] [Abstract][Full Text] [Related]
8. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
11. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
12. Reversion of human prostate tumorigenic growth by azatyrosine.
Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
[TBL] [Abstract][Full Text] [Related]
13. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
Missale C; Losa M; Sigala S; Balsari A; Giovanelli M; Spano PF
Mol Endocrinol; 1996 Mar; 10(3):272-85. PubMed ID: 8833656
[TBL] [Abstract][Full Text] [Related]
15. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
[TBL] [Abstract][Full Text] [Related]
16. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
17. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
White A; Lamb PW; Barrett JC
Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
[TBL] [Abstract][Full Text] [Related]
18. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
